AVRA was organized by a senior leadership team with broad and deep experience in medical research, innovation and development in the medical robotics field. The Company plans to exploit the growing demand for practical medical robotic devices by developing a platform - independent precision guidance system with an initial focus on skin resurfacing.
The Company believes that progress in mechanical and software engineering has made possible lightweight and relatively inexpensive robotic devices for difficult procedures in various medical fields.
Our Management team has had direct design, engineering and manufacturing experience in complex mechanical operations as well as the administration and supervision of the corporate activities of small and large enterprises ranging from pharma to telecommunications.
Our Medical Advisory Board consists of a number of surgeons who were active in the formative stages of robotic surgery in the United States and who today are numbered the most acknowledged and productive physicians in their specialties.
AVRA believes that its comprehensive and diverse team brings the necessary resources, including intellectual property, to develop and commercialize intelligent medical robotic systems, as well as in marketing, chain management, and the implementation of all other aspects of business operations.
New Initiative In Medical Robotics To Address Major Market Opportunities
Medical robots are realizing their potential in terms of improved accuracy, visualization and applications with their use expanding. Current medical robotic devices are typically large in-place systems with procedure-specific configurations requiring the assistance of the physician or operator.
AVRA Medical Robotics, Inc. "AVRA" has identified the significant need for a programmable autonomous robotic system with integrated image-guidance navigation in a single arm capable of modular configurations. It will be compact, rapidly programmable, procedurally wide-ranging, cost-effective and capable of performing minimally invasive procedures, such as biopsies, to more invasive surgical interventions both in an ambulatory setting and the operating room.
Toward this objective, in May 2016 AVRA partnered with the University of Central Florida College of Engineering and Computer Science to develop the algorithms, sensors, navigation and control components of the system. The College is particularly recognized for its work in the area of robotic research and design. Chair Professor Zhihua Qu and Research Professor Eytan Pollak are leading the program.
Professors Qu and Pollak have extensive backgrounds in the development of computer-operated systems that encompass the integration of tools and sensors, real-time image/data processing, navigation, control and human-machine interface. AVRA has filed for six provisional patents and is working with the College to file additional patents based on the work completed so far.
In reviewing marketing opportunities, we have initially identified a current, high-priority, fast growing market with a especially fitting and fully compatible use for our device - the skin resurfacing market.
–Three applications dominate that market –
Botox Laser Treatments and Micro-Needling (dermabrasion)
AVRA will initially focus on the micro-needling segment where we believe the use of our programmed, semi-autonomous robotic device with the appropriate tools, will comprehensively treat wrinkled skin with a precision beyond what is possible with manual application. The Company hopes these results will lead to an expansion of the micro-needling segment of the total resurfacing market. Presently, we are not aware of any commercially available robotic devices designed for this application.
The target for AVRA’s first planned medical robotic system, the non-surgical skin resurfacing market, has experienced explosive growth and is foreseen to continue this fast growth well into the future.
On February 14, 2017, AVRA filed a Registration on Form S-1 with the U.S. Securities and Exchange Commission covering the resale of certain of our outstanding shares of common stock with a view to becoming a fully reporting public company. The Registration Statement is currently in the comment stage and may be viewed at:
Any medical information published on this website is intended purely as a informational tool only and is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.
The Copyright of all images and documents is by the According Developing Group, Institute, Editor or Company. We only included data and images freely accessible. We have linked each image and/or story back to it's original source. If you want your system or certain information on it removed from our website, please contact us at email@example.com